Pfizer Says Its Covid Antiviral Pill Is Effective Against Omicron Variant

Pfizer released three laboratory studies Tuesday showing Paxlovid is effective at treating the omicron variant of the coronaviruses, despite uncertainty over whether other common Covid-19 treatments work against it.
The photo illustration is by Jakub Porzycki.

The images are from the same source.

Pfizer said in a press release that one of the lab studies found that nirmatrelvir was effective at staving off anidase that the coronaviruses needs to replicate in both the omicron variant and the original variant.

The statement said that the drug showed similar activity against previous coronaviruses.

A third study conducted by Pfizer and New York's Icahn School of Medicine at Mount Sinai found that Paxlovid was needed to be effective against previous versions.

Pfizer said last month that Paxlovid is effective at preventing hospitalization or death in high-risk Covid-19 patients.

Paxlovid will be delivered to the U.S. government in 20 million treatment courses.

99.5% of the time. The Centers for Disease Control and Prevention estimates that omicron caused last week's U.S. Covid-19 cases. The rest of the cases are made up of the delta variant.

Paxlovid was given emergency use authorization by the FDA. The country continues to grapple with an omicron-driven wave of infections, and Dr. Fauci said that drugs such as Paxlovid and molnupiravir will help put an end to the epidemic. Monoclonal antibody therapies by Eli Lilly and Regeneron have struggled against the omicron variant. The Department of Health and Human Services temporarily paused distribution of those two treatments for more than a week last month, before restarting shipments to states on the grounds that they are still effective against the delta variant.

There was aContra.

The best way to prevent the spread of Covid-19 is by getting a vaccine, according to many health experts. Fauci said during a White House news briefing last week that the chances of getting sick from the vaccine are very low.

There is a structure called the Tangent.

Hospitals in Michigan, New York, Ohio and Rhode Island are running out of Paxlovid and other Covid-19 treatments. CNN reported last week that around 160,000 courses of Paxlovid have been distributed, far too little to deal with a recent spike in Covid-related hospitalizations. According to the CDC, an average of 20,808 Americans were hospitalized for Covid-19 every day last week, up 4.2% from the previous seven day period.
Pfizer's new Covid-19 pill works against Omicron in a lab.

The Biden Administration ordered Pfizer to make the anti-covid pill.

Pfizer's Antiviral Covid Treatment pills can be used for emergency use.

Pfizer says that new data shows that the Covid Antiviral Drug is effective at preventing hospitalizations and deaths.

The U.S. paused distribution ofonoclonal Antibody Treatments that proved effective against Omicron.

Coverage and live updates on the coronaviruses.